Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|October 22, 2014
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2009
Inhaled voriconazole for prevention of invasive pulmonary aspergillosisJustin A Tolman, Nathan P Wiederhold, Jason T McConville, et al.
BMC Infectious Diseases|May 30, 2019
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 dataJie Jin, Depei Wu, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2008
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative cultureAna C Vallor, William R Kirkpatrick, Laura K Najvar, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitisNathan P Wiederhold, Lisa F Shubitz, Laura K Najvar, et al.
Medical Mycology|April 8, 2010
Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patientSteven D Westbrook, Nathan P Wiederhold, Ana C Vallor, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.
Journal of Clinical Microbiology|January 22, 2016
Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal ModelP Lewis White, Nathan P Wiederhold, Juergen Loeffler, et al.
Open Forum Infectious Diseases|July 18, 2025
COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis-Results of the Prospective MSG-017 StudyM Hong Nguyen, Sixto M Leal, Luis Ostrosky-Zeichner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.
Pageof 19